Emergent BioSolutions Reaches Oversold Status

Avatar photo

Warren Buffett’s investment philosophy urges caution when others are greedy and boldness in times of fear. Emergent BioSolutions Inc (EBS) has recently shown signs of fear, hitting an oversold level with a Relative Strength Index (RSI) of 20.6 during trading on Thursday, where shares dipped to as low as $5.06.

In contrast, the S&P 500 ETF (SPY) has a current RSI of 63.5. EBS’s 52-week performance shows a low of $5.06 and a high of $14.06, with the last trade recorded at $5.31. Investors may view the low RSI as a potential indicator to seek buying opportunities after the recent heavy selling.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

The free Daily Market Overview 250k traders and investors are reading

Read Now